Finland regulatory report: CBD classed as a medicine

$750.00

  • Executive summary
  • Hemp plant
  • Extracts
  • Finished products containing extracts
  • Import and export requirements
  • Medical cannabis
  • Recreational use
  • Relevant laws
  • Relevant bodies

Description

Having been classed as a medicine, CBD faces many restrictions for use in finished products or as a food. Further rules apply for cannabis use, cultivation and importation, and likewise for hemp. This report examines the strict regulation of hemp and CBD in theory and in practice, ensuring you are able to follow the necessary procedures to operate in this complex market.

Publication date: 9th December 2019; Total number of pages: 8

Photo: Ozgu Ozden

CBD-Intel does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CBD-Intel, does not accept any liability or responsibility for information or views published.